Brighton Collaboration (BC) has been added to the Vaccine Safety Net (VSN). VSN is a global network of websites, established by the World Health Organization (WHO), that provides reliable information…
Vaccine monitoring Collaboration for Europe (VAC4EU) and the Brighton Collaboration's Safety Platform for Emergency vACcines (SPEAC) project jointly held a scientific webinar on how to assess Vaccine Mediated Enhanced Disease…
Brighton Collaboration's Webinar on Tools for COVID-19 Vaccine Safety Assessment was held on Thursday, August 27th at 11 AM - 12:30 PM EDT | 5 PM - 6:30 PM CEST.For…
Several inactivated viral vaccine candidates are among the COVID-19 vaccines in development. The Brighton Collaboration (BC) Benefit-Risk Assessment of VAccines by TechnolOgy (BRAVATO), as part of the Safety Platform for Emergency…
Digital apps have much potential for improving the quality of safety data collected during both pre and post-introduction of new vaccines, including SARS-COV-2 candidate vaccines. Brighton Collaboration (BC) is forming two inter-related…
The Coalition for Epidemic Preparedness Innovation (CEPI) has partnered with the Brighton Collaboration to support the safety assessment of its candidate vaccines, including SARS-COV-2. Four AESI have been targeted for case…
Several protein vaccine candidates are among the COVID-19 vaccines in development. The Brighton Collaboration's Benefit-Risk Assessment of VAccines by TechnolOgy (BRAVATO), as part of the Safety Platform for Emergency vACcines (SPEAC)…
The COVID-19 pandemic has devastated the world as we know it. Nucleic acid (DNA and RNA) vaccines are among the most advanced vaccines for COVID-19 under development. These vaccine technology…
The Coalition for Epidemic Preparedness Innovations (CEPI) has contracted with the Brighton Collaboration, through the Task Force for Global Health (TFGH), to harmonize the safety assessment of CEPI-funded vaccines via…
Since the emergence of a new coronavirus, SARS-CoV-2, in China, there has been an unprecedented need to quickly develop an effective vaccine in light of the pandemic that was declared…